Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Non-Current Debt (2016 - 2025)

Surgery Partners (SGRY) has disclosed Non-Current Debt for 12 consecutive years, with $3.6 billion as the latest value for Q4 2025.

  • Quarterly Non-Current Debt rose 10.22% to $3.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.6 billion through Dec 2025, up 10.22% year-over-year, with the annual reading at $3.6 billion for FY2025, 10.22% up from the prior year.
  • Non-Current Debt hit $3.6 billion in Q4 2025 for Surgery Partners, up from $3.5 billion in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $3.6 billion in Q4 2025 to a low of $2.5 billion in Q2 2023.
  • Historically, Non-Current Debt has averaged $3.0 billion across 5 years, with a median of $2.9 billion in 2021.
  • Biggest five-year swings in Non-Current Debt: dropped 17.04% in 2023 and later grew 23.38% in 2025.
  • Year by year, Non-Current Debt stood at $2.9 billion in 2021, then decreased by 11.1% to $2.6 billion in 2022, then rose by 5.58% to $2.7 billion in 2023, then grew by 20.99% to $3.3 billion in 2024, then rose by 10.22% to $3.6 billion in 2025.
  • Business Quant data shows Non-Current Debt for SGRY at $3.6 billion in Q4 2025, $3.5 billion in Q3 2025, and $3.5 billion in Q2 2025.